Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Cyclosporin A-15N11, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco C1391ML

Catalog No. 01-001-098


Explore available promotions
Add to Cart

Description

Description

A stable-labeled internal standard of cyclosporin A, an immunosuppressant and narrow therapeutic index drug used to prevent rejection in organ transplantation. This internal standard is suitable for critical quantitative applications in clinical and diagnostic testing such as therapeutic drug monitoring assays to ensure patients remain within the drug's narrow therapeutic range. The Snap-N-Spike™ format allows laboratories to eliminate weighing operations of hazardous substances such as cyclosporin A, significantly reducing occupational exposure hazards related to handling of acutely toxic powders and provides the ability to spike into their matrix of choice before use.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

75-05-8
UN 1648 3 / PGII
1213.54
1 mL
C62H11115N11O12
100 μg/mL in acetonitrile
Ampule
2°C (35.6°F) - closed cup
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

H332-H319

H312

Recommended Storage : -70°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

CERILLIANT is a registered trademark of Cerilliant Corporation